|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0660 AUD | +3.12% |
|
0.00% | -22.35% |
| 12/06 | Neurizon Therapeutics Surpasses 50% Dosing Milestone in Trial of ALS Treatment | MT |
| 27/05 | Neurizon Therapeutics Limited Expands Regimen I of the Healey Als Platform Trial to 240 Participants | CI |
Insider Transaction History
Latest insider transactions for Neurizon Therapeutics Limited
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 07/24/07 | Buy | Director | 2,63,158 | 0.19 | 50T | 0.0541% | ||
| 07/24/07 | Buy | Director | 26,31,579 | 0.19 | 5L | 0.5408% | ||
| 07/24/07 | Free | Director | 42,56,000 | - | - | 0.8746% | ||
| 07/24/07 | Free | Director | 11,40,000 | - | - | 0.2343% | ||
| 07/24/07 | Buy | Chairman | 13,15,789 | 0.19 | 2L | 0.2704% | ||
| 07/24/07 | Buy | Director | 2,63,158 | 0.19 | 50T | 0.0541% | ||
| 07/24/07 | Buy | Director | 26,31,579 | 0.19 | 5L | 0.5408% | ||
| 28/24/28 | Buy | Director | 1,57,895 | 0.19 | 29.98T | 0.0355% | ||
| 28/24/28 | Buy | Director | 1,57,895 | 0.19 | 29.98T | 0.0355% | ||
| 28/24/28 | Buy | Director | 1,57,895 | 0.19 | 29.98T | 0.0355% | ||
- Stock Market
- Stocks
- NUZ Stock
- Company Neurizon Therapeutics Limited
- Insider transactions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition